Alyeska Investment Group
KIN

Alyeska Investment Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Alyeska Investment Group’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-283,942
Closed -$2.37M – 543
2019
Q2 		$2.37M Sell
283,942
-126,270
-31% -$1.09M 0.03% 302
2019
Q1 		$3.76M Buy
+410,212
New +$4.17M 0.05% 245

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group's KIN Position: Q3 2019 in Review

Alyeska Investment Group sold out of Kindred Biosciences, Inc. (KIN) in Q3 2019, closing a stake of 283,942 shares — an estimated $2.37M sold.

Alyeska Investment Group first reported a position in KIN in Q1 2019 and held it in 2 quarters. The position peaked at $3.76M in Q1 2019. 72 funds tracked by Wall St. Rank hold KIN as of Q3 2019.

  • Alyeska Investment Group reported no remaining Kindred Biosciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 283,942 Kindred Biosciences, Inc. shares in Q3 2019, an estimated $2.37M.
  • Alyeska Investment Group first reported a position in Kindred Biosciences, Inc. in Q1 2019 and held it in 2 quarters.
  • Alyeska Investment Group's Kindred Biosciences, Inc. position peaked at $3.76M in Q1 2019.
  • 72 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.